{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T06:52:49Z","timestamp":1769928769446,"version":"3.49.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2005,11,1]],"date-time":"2005-11-01T00:00:00Z","timestamp":1130803200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hautarzt"],"published-print":{"date-parts":[[2005,11]]},"DOI":"10.1007\/s00105-005-1043-1","type":"journal-article","created":{"date-parts":[[2005,10,7]],"date-time":"2005-10-07T17:32:26Z","timestamp":1128706346000},"page":"1013-1017","source":"Crossref","is-referenced-by-count":6,"title":["Pathophysiologie der Akne","Pathophysiology of acne"],"prefix":"10.1007","volume":"56","author":[{"given":"C.","family":"Borelli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Plewig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Degitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"1043_CR1","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1365-2133.1987.tb04114.x","volume":"117","author":"Allaker","year":"1987","unstructured":"Allaker RP, Greenman J, Osborne RH (1987) The production of inflammatory compounds by Propionibacterium acnes and other skin organisms. Br J Dermatol 117:175\u2013183","journal-title":"Br J Dermatol"},{"key":"1043_CR2","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1677\/joe.0.1330467","volume":"133","author":"Choudhry","year":"1992","unstructured":"Choudhry R, Hodgins MB, Van der Kwast TH et al. (1992) Localization of androgen receptors in human skin by immunohistochemistry: implications for the hormonal regulation of hair growth, sebaceous glands and sweat glands. J Endocrinol 133:467\u2013475","journal-title":"J Endocrinol"},{"key":"1043_CR3","doi-asserted-by":"crossref","unstructured":"Cunliffe WJ, Gollnick HPM (2004) Akne, Pathophysiologie, Klinik, Diagnose und Therapie. Dunitz, London","DOI":"10.3109\/9780203492642"},{"key":"1043_CR4","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1046\/j.1365-2133.2000.03531.x","volume":"142","author":"Cunliffe","year":"2000","unstructured":"Cunliffe WJ, Holland DB, Clark SM, Stables GI (2000) Comedogenesis: some new aetiological, clinical and therapeutic strategies. Br J Dermatol 142:1084\u20131091","journal-title":"Br J Dermatol"},{"key":"1043_CR5","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/1523-1747.ep12264715","volume":"83","author":"De","year":"1984","unstructured":"De Young LM, Young JM, Ballaron SJ et al. (1984) Intradermal injection of Propionibacterium acnes: a model of inflammation relevant to acne. J Invest Dermatol 83:394\u2013398","journal-title":"J Invest Dermatol"},{"key":"1043_CR6","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1067\/mjd.2003.618","volume":"49","author":"Gollnick","year":"2003","unstructured":"Gollnick H, Cunliffe W, Berson D et al. (2003) Management of acne: a report from a Global Alliance to Improve Outcomes in Acne. J Am Acad Dermatol 49:S1\u201337","journal-title":"J Am Acad Dermatol"},{"key":"1043_CR7","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1046\/j.1365-2133.2004.05762.x","volume":"150","author":"Graham","year":"2004","unstructured":"Graham GM, Farrar MD, Cruse-Sawyer JE et al. (2004) Proinflammatory cytokine production by human keratinocytes stimulated with Propionibacterium acnes and P. acnes GroEL. Br J Dermatol 150:421\u2013428","journal-title":"Br J Dermatol"},{"key":"1043_CR8","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1159\/000017862","volume":"196","author":"Guy","year":"1998","unstructured":"Guy R, Kealey T (1998) Modelling the infundibulum in acne. Dermatology 196:32\u201337","journal-title":"Dermatology"},{"key":"1043_CR9","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/1523-1747.ep12343608","volume":"106","author":"Guy","year":"1996","unstructured":"Guy R, Ridden C, Kealey T (1996) The improved organ maintenance of the human sebaceous gland: modeling in vitro the effects of epidermal growth factor, androgens, estrogens, 13-cis retinoic acid, and phenol red. J Invest Dermatol 106:454\u2013460","journal-title":"J Invest Dermatol"},{"key":"1043_CR10","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1111\/1523-1747.ep12460324","volume":"98","author":"Ingham","year":"1992","unstructured":"Ingham E, Eady EA, Goodwin CE et al. (1992) Pro-inflammatory levels of interleukin-1 alpha-like bioactivity are present in the majority of open comedones in acne vulgaris. J Invest Dermatol 98:895\u2013901","journal-title":"J Invest Dermatol"},{"key":"1043_CR11","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1080\/00015550310016463","volume":"83","author":"Jappe","year":"2003","unstructured":"Jappe U (2003) Pathological mechanisms of acne with special emphasis on Propionibacterium acnes and related therapy. Acta Derm Venereol 83:241\u2013248","journal-title":"Acta Derm Venereol"},{"key":"1043_CR12","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1046\/j.1365-2133.2002.04602.x","volume":"146","author":"Jappe","year":"2002","unstructured":"Jappe U, Ingham E, Henwood J, Holland KT (2002) Propionibacterium acnes and inflammation in acne; P. acnes has T-cell mitogenic activity. Br J Dermatol 146:202\u2013209","journal-title":"Br J Dermatol"},{"key":"1043_CR13","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1046\/j.1523-1747.2003.12321.x","volume":"121","author":"Jeremy","year":"2003","unstructured":"Jeremy AH, Holland DB, Roberts SG et al. (2003) Inflammatory events are involved in acne lesion initiation. J Invest Dermatol 121:20\u201327","journal-title":"J Invest Dermatol"},{"key":"1043_CR14","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.4049\/jimmunol.169.3.1535","volume":"169","author":"Kim","year":"2002","unstructured":"Kim J, Ochoa MT, Krutzik SR et al. (2002) Activation of toll-like receptor 2 in acne triggers inflammatory cytokine responses. J Immunol 169:1535\u20131541","journal-title":"J Immunol"},{"key":"1043_CR15","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1001\/archderm.1963.01590240156026","volume":"88","author":"Kirschbaum","year":"1963","unstructured":"Kirschbaum JO, Kligman AM (1963) The pathogenic role of corynebacterium acnes in acne vulgaris. Arch Dermatol 88:832\u2013833","journal-title":"Arch Dermatol"},{"key":"1043_CR16","first-page":"44","volume":"13","author":"Knor","year":"2005","unstructured":"Knor T (2005) The pathogenesis of acne. Acta Dermatovenerol Croat 13:44\u201349","journal-title":"Acta Dermatovenerol Croat"},{"key":"1043_CR17","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.jaad.2003.07.021","volume":"50","author":"Leyden","year":"2004","unstructured":"Leyden J, Bergfeld W, Drake L et al. (2004) A systemic type I 5 alpha-reductase inhibitor is ineffective in the treatment of acne vulgaris. J Am Acad Dermatol 50:443\u2013447","journal-title":"J Am Acad Dermatol"},{"key":"1043_CR18","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1016\/0190-9622(95)90416-6","volume":"32","author":"Leyden","year":"1995","unstructured":"Leyden JJ (1995) New understandings of the pathogenesis of acne. J Am Acad Dermatol 32:S15\u201325","journal-title":"J Am Acad Dermatol"},{"key":"1043_CR19","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/1523-1747.ep12607630","volume":"65","author":"Leyden","year":"1975","unstructured":"Leyden JJ, McGinley KJ, Mills OH, Kligman AM (1975) Age-related changes in the resident bacterial flora of the human face. J Invest Dermatol 65:379\u2013381","journal-title":"J Invest Dermatol"},{"key":"1043_CR20","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/1523-1747.ep12607634","volume":"65","author":"Leyden","year":"1975","unstructured":"Leyden JJ, McGinley KJ, Mills OH, Kligman AM (1975) Propionibacterium levels in patients with and without acne vulgaris. J Invest Dermatol 65:382\u2013384","journal-title":"J Invest Dermatol"},{"key":"1043_CR21","doi-asserted-by":"crossref","first-page":"89S","DOI":"10.1016\/S0002-9343(99)80064-3","volume":"98","author":"Lucky","year":"1995","unstructured":"Lucky AW (1995) Hormonal correlates of acne and hirsutism. Am J Med 98:89S\u201394S","journal-title":"Am J Med"},{"key":"1043_CR22","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.sder.2005.03.002","volume":"24","author":"McInturff","year":"2005","unstructured":"McInturff JE, Kim J (2005) The role of toll-like receptors in the pathophysiology of acne. Semin Cutan Med Surg 24:73\u201378","journal-title":"Semin Cutan Med Surg"},{"key":"1043_CR23","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1111\/j.1523-1747.2003.12630.x","volume":"121","author":"Mempel","year":"2003","unstructured":"Mempel M, Voelcker V, Kollisch G et al. (2003) Toll-like receptor expression in human keratinocytes: nuclear factor kappaB controlled gene activation by Staphylococcus aureus is toll-like receptor 2 but not toll-like receptor 4 or platelet activating factor receptor dependent. J Invest Dermatol 121:1389\u20131396","journal-title":"J Invest Dermatol"},{"key":"1043_CR24","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/j.1365-2133.1988.tb02566.x","volume":"118","author":"Norris","year":"1988","unstructured":"Norris JF, Cunliffe WJ (1988) A histological and immunocytochemical study of early acne lesions. Br J Dermatol 118:651\u2013659","journal-title":"Br J Dermatol"},{"key":"1043_CR25","doi-asserted-by":"crossref","unstructured":"Plewig G, Kligman AM (2000) Acne and Rosacea. 3rd ed. Springer, Berlin","DOI":"10.1007\/978-3-642-59715-2"},{"key":"1043_CR26","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1365-2133.2005.06530.x","volume":"153","author":"Schaller","year":"2005","unstructured":"Schaller M, Loewenstein M, Borelli C et al. (2005) Induction of a chemoattractive proinflammatory cytokine response after stimulation of keratinocytes with Propionibacterium acnes and coproporphyrin III. Br J Dermatol 153:66\u201371","journal-title":"Br J Dermatol"},{"key":"1043_CR27","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1159\/000067823","volume":"206","author":"Thiboutot","year":"2003","unstructured":"Thiboutot D, Chen W (2003) Update and future of hormonal therapy in acne. Dermatology 206:57\u201367","journal-title":"Dermatology"},{"key":"1043_CR28","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.1128\/IAI.63.8.3158-3165.1995","volume":"63","author":"Vowels","year":"1995","unstructured":"Vowels BR, Yang S, Leyden JJ (1995) Induction of proinflammatory cytokines by a soluble factor of Propionibacterium acnes: implications for chronic inflammatory acne. Infect Immun 63:3158\u20133165","journal-title":"Infect Immun"},{"key":"1043_CR29","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1159\/000017875","volume":"196","author":"Webster","year":"1998","unstructured":"Webster GF (1998) Inflammatory acne represents hypersensitivity to Propionibacterium acnes. Dermatology 196:80\u201381","journal-title":"Dermatology"},{"key":"1043_CR30","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/1523-1747.ep12531636","volume":"73","author":"Webster","year":"1979","unstructured":"Webster GF, Kligman AM (1979) A method for the assay of inflammatory mediators in follicular casts. J Invest Dermatol 73:266\u2013268","journal-title":"J Invest Dermatol"},{"key":"1043_CR31","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1128\/IAI.22.2.523-529.1978","volume":"22","author":"Webster","year":"1978","unstructured":"Webster GF, Leyden JJ, Norman ME, Nilsson UR (1978) Complement activation in acne vulgaris: in vitro studies with Propionibacterium acnes and Propionibacterium granulosum. Infect Immun 22:523\u2013529","journal-title":"Infect Immun"},{"key":"1043_CR32","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1001\/archderm.139.5.668","volume":"139","author":"Zouboulis","year":"2003","unstructured":"Zouboulis CC, Nestoris S, Adler YD, Orth M, Orfanos CE, Picardo M, Camera E, Cunliffe WJ (2003) A new concept for acne therapy: a pilot study with zileuton, an oral 5-lipoxygenase inhibitor. Arch Dermatol 139:668\u2013670","journal-title":"Arch Dermatol"},{"key":"1043_CR33","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1159\/000081481","volume":"210","author":"Zouboulis","year":"2005","unstructured":"Zouboulis Ch C, Saborowski A, Boschnakow A (2005) Zileuton, an oral 5-lipoxygenase inhibitor, directly reduces sebum production. Dermatology 210:36\u201338","journal-title":"Dermatology"}],"container-title":["Der Hautarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-005-1043-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00105-005-1043-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-005-1043-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,10]],"date-time":"2020-04-10T06:20:10Z","timestamp":1586499610000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00105-005-1043-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11]]},"references-count":33,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2005,11]]}},"alternative-id":["1043"],"URL":"https:\/\/doi.org\/10.1007\/s00105-005-1043-1","relation":{},"ISSN":["0017-8470","1432-1173"],"issn-type":[{"value":"0017-8470","type":"print"},{"value":"1432-1173","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,11]]}}}